Most Read News

The collaboration is committed to providing intelligent, energy-saving lighting solutions to address India's increasingly sophisticated growing infrastructure business needs.

For the Q1 FY26, Wipro has guided QoQ-sequentially revenue between $2,505 million and $2,557 million, implying a possible sequential fall of 1.5% to 3.5%

Gross NPA ratio reduced to 1.67% as of 31st March 2025, from 1.96% previous quarter and 2.16% same quarter last year.

EBITDA for the quarter was ₹122.4 crore, up 62.8% year-on-year, even as EBITDA margins fell marginally to 25.7%, from 27.5% in Q4 FY24

The clearance is on the back of a four-day USFDA inspection between June 10 and June 13, 2024.

The approved product is the generic equivalent of Tegretol Tablets 200 mg, which was initially developed by Novartis Pharmaceuticals Corporation.

The drug consists of a combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate.

Revenue grew 4.8% year-on-year in constant currency terms but declined 3.5% quarter-on-quarter.

The wind power project will be undertaken in Jath, Maharashtra, where Suzlon will deploy 48 S120 wind turbine generators, each of 2.1 MW capacity.

EBIT margin declined to 20.1% in Q4 FY25 from 23.5% in Q3.